Literature DB >> 15895268

"Medicamentation" of society, non-diseases and non-medications: a point of view from social pharmacology.

T B Ngoundo Mbongue1, A Sommet, A Pathak, J L Montastruc.   

Abstract

This review presents the definition and goals of "social pharmacology", a new branch of clinical pharmacology, investigating relationships between drugs and society through the example of "medicamentation", defined as the use of drugs for social problems previously not requiring drug utilisation (ageing, smoking cessation, vigilance troubles, sleep synchronisation, loss of libido, etc.). The involvement of the different "actors" from our society (patients, physicians, pharmaceutical industries, clinical pharmacologists, regulatory agencies, etc.) in this phenomenon is also discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15895268     DOI: 10.1007/s00228-005-0925-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Promotion of prescription drugs to consumers.

Authors:  Meredith B Rosenthal; Ernst R Berndt; Julie M Donohue; Richard G Frank; Arnold M Epstein
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

2.  Health spending projections for 2001-2011: the latest outlook.

Authors:  Stephen Heffler; Sheila Smith; Greg Won; M Kent Clemens; Sean Keehan; Mark Zezza
Journal:  Health Aff (Millwood)       Date:  2002 Mar-Apr       Impact factor: 6.301

3.  Fewer new drugs from the pharmaceutical industry.

Authors:  David Taylor
Journal:  BMJ       Date:  2003-02-22

4.  Controversial disease dropped from Prozac product information.

Authors:  Ray Moynihan
Journal:  BMJ       Date:  2004-02-14

5.  Pressure to prescribe.

Authors:  T Greenhalgh; P Gill
Journal:  BMJ       Date:  1997-12-06

6.  The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey.

Authors:  N Britten; O Ukoumunne
Journal:  BMJ       Date:  1997-12-06

7.  From experimental to social pharmacology. Natural history of pharmacology.

Authors:  J Venulet
Journal:  Int J Clin Pharmacol       Date:  1974-10

8.  [A pilot study in general practice: pressure to prescribe].

Authors:  Catherine Delga; Yves Megnin; Stéphane Oustric; Christian Laurent; Laurent Pauly; Jean-Pierre Vergez; Jean-Paul Charlet; Jean-Louis Montastruc; Philippe Arlet
Journal:  Therapie       Date:  2003 Nov-Dec       Impact factor: 2.070

9.  European healthcare policies for controlling drug expenditure.

Authors:  Silvia M Ess; Sebastian Schneeweiss; Thomas D Szucs
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Internet-based patient self-care: the next generation of health care delivery.

Authors:  June Forkner-Dunn
Journal:  J Med Internet Res       Date:  2003 Apr-Jun       Impact factor: 5.428

View more
  6 in total

1.  Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course.

Authors:  G Durrieu; C Hurault; V Bongard; C Damase-Michel; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  2007-03-22       Impact factor: 4.335

2.  Undesirable effects related to oral antineoplastic drugs: comparison between patients' internet narratives and a national pharmacovigilance database.

Authors:  Arnaud Pages; Emmanuelle Bondon-Guitton; Jean Louis Montastruc; Haleh Bagheri
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606

Review 3.  [Lifestyle drugs in medicine].

Authors:  Wolfgang Harth; Kurt Seikowski; Barbara Hermes; Uwe Gieler
Journal:  Wien Med Wochenschr       Date:  2008

Review 4.  Social pharmacology: expanding horizons.

Authors:  Rituparna Maiti; José Luis Alloza
Journal:  Indian J Pharmacol       Date:  2014 May-Jun       Impact factor: 1.200

5.  COVID-19 vaccines: A perspective from social pharmacology.

Authors:  Jean-Louis Montastruc; Margaux Lafaurie; Claire de Canecaude; François Montastruc; Haleh Bagheri; Geneviève Durrieu; Agnès Sommet
Journal:  Therapie       Date:  2021-05-28       Impact factor: 2.070

6.  Psychological drivers in doping: the life-cycle model of performance enhancement.

Authors:  Andrea Petróczi; Eugene Aidman
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.